Literature DB >> 14984550

Mechanisms of vasomotor rhinitis.

R Garay1.   

Abstract

Nonallergic non-infectious perennial rhinitis (NANIPER) is a heterogeneous disorder comprising several pathophysiological entities. The etiology of some of these disorders (e.g. drug-induced rhinitis, nonallergic rhinitis with eosinophilia syndrome [NARES], occupational rhinitis, hormonal rhinitis, emotion-induced rhinitis, physical/chemical irritant-induced rhinitis) is well established. In contrast, the aetiology of idiopathic forms of rhinitis (also known as vasomotor rhinitis) is largely unknown. Mechanistic studies have suggested that non-IgE-mediated inflammatory and/or neurogenic processes may be involved. There is evidence that localized inflammation is the underlying cause of symptoms in drug-induced rhinitis and NARES, since eosinophilia is an important pathophysiological component in these conditions. In contrast, neurogenic reflex mechanisms initiated by environmental factors appear to be involved in idiopathic rhinitis. It has been suggested that there may be an imbalance of the sympathetic and parasympathetic nervous systems, with parasympathetic hyper-activity and sympathetic hypo-activity resulting in nasal congestion and rhinorrhoea. Indirect evidence suggests that C-fibres may also play an important role in the pathophysiology of idiopathic rhinitis.

Entities:  

Mesh:

Year:  2004        PMID: 14984550     DOI: 10.1111/j.0108-1675.2004.00388.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  12 in total

1.  Epidemiological analysis of chronic rhinitis in pediatric patients.

Authors:  Elizabeth A Erwin; Russell A Faust; Thomas A E Platts-Mills; Larry Borish
Journal:  Am J Rhinol Allergy       Date:  2011 Sep-Oct       Impact factor: 2.467

2.  A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis.

Authors:  Jonathan A Bernstein; Benjamin P Davis; Jillian K Picard; Jennifer P Cooper; Shu Zheng; Linda S Levin
Journal:  Ann Allergy Asthma Immunol       Date:  2011-06-29       Impact factor: 6.347

Review 3.  Nonallergic rhinitis.

Authors:  Phil Lieberman; Debendra Pattanaik
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

4.  Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system.

Authors:  Junji Narioka; Yuichi Ohashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

Review 5.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Relationship between environment factors and the number of outpatient visits at a clinic for nonallergic rhinitis in Japan, extracted from electronic medical records.

Authors:  Takayuki Hoshino; Ayami Hoshino; Junya Nishino
Journal:  Eur J Med Res       Date:  2015-07-08       Impact factor: 2.175

7.  TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis.

Authors:  Maria Lauriello; Alessandra Micera; Paola Muzi; Lino Di Rienzo Businco; Sergio Bonini
Journal:  Int J Otolaryngol       Date:  2012-04-10

8.  The role of antihistamines in the treatment of vasomotor rhinitis.

Authors:  Phil Lieberman
Journal:  World Allergy Organ J       Date:  2009-08-15       Impact factor: 4.084

9.  The treatment of vasomotor rhinitis with intranasal corticosteroids.

Authors:  Eli O Meltzer
Journal:  World Allergy Organ J       Date:  2009-08-15       Impact factor: 4.084

10.  Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis.

Authors:  Michael A Kaliner; James N Baraniuk; Michael S Benninger; Jonathan A Bernstein; Phil Lieberman; Eli O Meltzer; Robert M Naclerio; Russell A Settipane; Judith R Farrar
Journal:  World Allergy Organ J       Date:  2009-08-15       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.